This study pioneers the systematic elucidation of ARL5B's overexpression in ESCC through clinical specimen and cellular model analyses, and evaluates its functional contributions to tumor progression to address this scientific void. The gene discussed is ARL5B; the disease is esophageal squamous cell carcinoma.